| 发明名称 |
COMBINATIONS OF HISTONE DEACETYLASE INHIBITORS AND BENDAMUSTINE |
| 摘要 |
The invention relates to pharmaceutical combinations comprising an HDAC inhibitor and bendamustine; pharmaceutical compositions comprising the same; and methods of using such combinations and compositions for treating lymphoma in a subject in need thereof. |
| 申请公布号 |
US2016158232(A1) |
申请公布日期 |
2016.06.09 |
| 申请号 |
US201514959473 |
申请日期 |
2015.12.04 |
| 申请人 |
University of Modena and Reggio Emilia |
发明人 |
Pozzi Samantha;Cosenza Maria |
| 分类号 |
A61K31/505;A61K31/4184 |
主分类号 |
A61K31/505 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A pharmaceutical combination for treating lymphoma comprising a therapeutically effective amount of a histone deacetylase 6 (HDAC6) specific inhibitor or a pharmaceutically acceptable salt thereof, and bendamustine or a pharmaceutically acceptable salt thereof. |
| 地址 |
Modena IT |
